Effect of glycolipid Rhodococcus biosurfactant on secretory activity of neutrophils in Vitro

Bulletin of Experimental Biology and Medicine

Volumn 157, Issue 2, 2014, Pages 238-242

  Baeva, T A ^a   Gein, S V ^c   Kuyukina, M S ^c   Ivshina, I B ^c   Kochina, O A ^b   Chereshnev, V A ^a,b,c  

^a INSTITUTE OF ECOLOGY AND GENETICS OF MICROORGANISMS   (Russian Federation)

^b PERM STATE UNIVERSITY   (Russian Federation)

^c INSTITUTE OF IMMUNOLOGY AND PHYSIOLOGY   (Russian Federation)

Author keywords

Cytokines; Glycolipid; Neutrophils; Reactive oxygen species; Rhodococcus ruber

Indexed keywords

BIOSURFACTANT; GLYCOLIPID BIOSURFACTANT; INTERLEUKIN 1BETA; INTERLEUKIN 8; NATURAL PRODUCT; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GLYCOLIPID; SURFACTANT;

ADULT; ARTICLE; DRUG EFFECT; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; NONHUMAN; RHODOCOCCUS RUBER; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; METABOLISM; RHODOCOCCUS;

CELLS, CULTURED; GLYCOLIPIDS; HUMANS; INTERLEUKIN-8; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RHODOCOCCUS; SURFACE-ACTIVE AGENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904289130     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-014-2534-9     Document Type: Article

References (15)

1. I. I. Dolgushin, Yu. S. Andreeva, and A. Yu. Savochkina, Neutrophil Traps and Methods for Assessing the Functional Status of Neutrophils [in Russian], Moscow (2009).
2. M. S. Kuyukina, I. B. Ivshina, S. V. Gein, et al., Bull. Exp. Biol. Med., 144, No. 3, 326-330 (2007).
3. V. A. Chereshnev, S. V. Gein, T. A. Baeva, et al., Bull. Exp. Biol. Med., 149, No. 6, 731-738 (2010).
4. J. Cortes-Sanchez Ade, H. Hernandez-Sanchez, M. E. Jaramillo-Flores, Microbiol Res., 168, No. 1, 22-32 (2012).
5. S. V. Gein, M. S. Kuyukina, I. B. Ivshina, et al., Cytotechnology, 63, No. 6, 559-566 (2011).
6. G. De Libero and L. Mori, Prog. Lipid Res., 49, No. 2, 120-127 (2010).
7. S. Gordon, Phagocytosis: Microbial Invasion, Vol. 6, Stamford, (1999).
8. M. M. Hoq, T. Suzutani, and T. Toyoda, et al., J. Gen. Virol., 78, Pt. 7, 1597-1603 (1997).
9. M. S. Kuyukina, I. B. Ivshina, J. C. Philp, et al., J. Microbiol. Methods, 46, No. 2, 149-156 (2001).
10. W. B. Lee, J. S. Kang, J. J. Yan, et al., PLoS Pathog., 8, No.4, e1002614 (2012).
11. A. Ozinsky, D. M. Underhill, J. D. Fontenot, et al., Prog. Natl. Acad. Sci., 97, No. 25, 13 766-13 771 (2000).
12. L. Rodrigues, I. M. Banat, J. Teixeira, et al., J. Antimicrob. Chemother., 57, No. 4, 609-618 (2006).
13. R. Ryll, Y. Kumazawa, and I. Yano, Microbiol. Immunol., 45, No. 12, 801-811 (2001).
14. I. Sakaguchi, N. Ikeda, N. Nakayama, et al., Infect. Immunity, 68, No. 4, 2043-2052 (2000).
15. E. Yarkoni and H. J. Rapp, Infect. Immun., 18, No. 2, 552-554 (1977).